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ABSTRACT
Aging is associated with an increase in the prevalence of obstructive sleep apnea 
syndrome (OSAS) as well as the shortening of telomeres. It is known that OSAS-related 
factors are stimuli that can contribute to the acceleration of cellular senescence. Thus, 
the present study aimed to compare the leukocyte telomere length (LTL) between 
OSAS patients and controls, as well as to verify the correlation between LTL and sleep 
parameters. We used DNA extracted of 928 individuals from EPISONO to measure 
the LTL by the quantitative real-time polymerase chain reaction. All individuals were 
subjected to one full-night polysomnography. LTL was significantly shorter in OSAS 
patients compared to controls. The results showed negative correlations between LTL 
and the following variables: apnea-hypopnea index, respiratory disturbance index, 
desaturation index and wake after sleep onset. LTL was positively correlated with 
sleep efficiency, total sleep time, basal, minimum and maximum oxygen saturation. 
Lastly, it was observed that OSAS severity was associated with shorter LTL even after 
adjusting for sex, age, years of schooling, body mass index, diabetes, stroke and heart 
attack. In conclusion, our study indicates the presence of an association between 
LTL and OSAS and a significant impact of severity of OSAS in telomeres shortening.
INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is a 
sleep related breathing disorder which is characterized by 
repetitive episodes of respiratory pauses (apnea) or partial 
upper airway obstruction (hypopnea). It is often associated 
with reduced blood oxygen saturation, snoring, sleep 
disruption and daytime sleepiness [1]. OSAS is known 
to stimulate oxidative stress, inflammation, sympathetic 
nervous system activation and endothelial dysfunction due 
mainly to sleep fragmentation and intermittent hypoxia 
mechanisms [2-7]. 
The core features of OSAS contribute to the 
exacerbation of inflammation and oxidative stress 
pathways [8]. Basic evidence has shown that intermittent 
hypoxia leads to recurrent blood oxygen desaturation, 
changes oxygen availability in many tissues, leading 
to an increase of pro-inflammatory cytokines and an 
imbalance between pro-oxidant and anti-oxidant systems 
resulting in excessive production of reactive oxygen 
species (ROS) [9]. Similarly, sleep fragmentation has been 
shown to promote increased expression and activation of 
nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase [5], an enzyme considered as major source of 
ROS generation in OSAS [8].
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The accumulation of oxidative damage caused by 
ROS has an impact on critical aspects of aging process and 
contributes physiological function impairment, increased 
incidence of disease, and reduction in life span [10]. ROS 
molecules have the potential to damage a number of vital 
biomolecules [8]. At the cellular level, ROS leads to DNA 
double strand breaks and telomere shortening, which are 
both important cell senescence triggers [10].
Telomeres are characterized by the presence 
of tandem repeats of non-coding DNA (TTAGGG/
CCCTAA) at the ends of chromosomes [11] and are 
responsible for protecting and stabilizing the terminal 
region of chromosomes, avoiding loss of coding DNA 
or chromosomal instability [12]. Telomere length 
tends to shorten with time, mainly due to the so called 
‘end replication problem’, but also being due to other 
causes such as oxidative stress [12], genetic factors and 
comorbidities [13-15]. Telomeres are reported to be a 
‘marker of biological aging’ since their length tends 
to diminish with age and be related to a higher risk of 
mortality [16]. Long telomeres are associated with 
decreased aging [13], while short telomeres are commonly 
found in several pathological conditions as an indicator of 
disease onset and related outcome [16]. 
Considering the fact that an important modulator 
of telomere maintenance is oxidative stress and that 
telomere-driven replicative senescence is primarily 
a stress response [17], evidences have pointed out to 
a potential association between OSAS and cellular 
aging, through telomere shortening [18-20]. Thus, we 
hypothesized that OSAS would be associated with shorter 
telomere length compared to control individuals without 
OSAS. Additionally, we aimed to assess the differences 
in the mean leukocyte telomere length (LTL) among mild, 
moderate and severe forms of OSAS as well as to verify 
the correlation between sleep parameters and LTL in an 
epidemiological framework. 
RESULTS
There were 613 individuals in the CTRL group and 
315 in the OSAS group. Within the OSAS group, 48.6% 
were mild (5 ≤ AHI < 15), 31.1% moderate (15 ≤ AHI 
< 30) and 20.3% severe (AHI ≥ 30). Table 1 shows the 
clinical parameters investigated according to the presence 
or absence of OSAS in the EPISONO cohort. As expected, 
the OSAS group was older (t = -13.9, df = 926, p < 0.001), 
Table 1: Non-adjusted mean ± standard deviation and frequency (%) of clinical characteristics from the EPISONO 




(n = 613) (n = 315)
Age (years) 38.4 ± 13 51.2 ± 13.7* <0.001
Men 38.7% 56.2%* <0.001
BMI (kg/m2) 25.5 ± 4.5 29.7 ± 5.9* <0.001
Years of Schooling 10.84 ± 4.5 10.4 ± 5.3 0.195
RDI 2.3 ± 2.9 13.6 ± 12.5* <0.001
AHI 1.9 ± 2.3 20.5 ± 16.5* <0.001
Basal SpO2 96.3 ± 1.4 95 ± 1.5* <0.001
Medium SpO2 95.7 ± 1.6 93.9 ± 1.9* <0.001
Minimum SpO2 90.6 ± 3.7 83.7 ± 6.1* <0.001
Arousal Index 11.36 ± 6.8 22.27 ± 14.2* <0.001
Sleep Latency (min) 16.03 ± 21.2 17.65 ± 23.5 0.289
REM Latency (min) 97.22 ± 47.4 109.39 ± 61.6* <0.001
N1 (%) 4.19 ± 3.2 5.18 ± 3.3* <0.001
N2 (%) 54.00 ± 8.8 55.98 ± 10.1* 0.002
N3 (%) 22.5 ± 7.7 20.35 ± 8.6* <0.001
REM (%) 19.29 ± 6.5 18.49 ± 6.6 0.078
WASO 53.43 ± 44.1 70.42 ± 46.5 <0.001
TST 348.72 ± 77.1 331.66 ± 73.3* <0.001
Sleep Efficiency 83.48 ± 12.3 79.10 ± 13.1* <0.001
Dessaturation index 1.9 ± 2.9 14.6 ± 14.3* <0.001
Presence of diabetes 2.1% 9.5%* <0.001
History of heart attack 1.3% 2.9% 0.201
History of stroke 1.1% 1.9% 0.554
CTRL: control; OSAS: obstructive sleep apnea syndrome; BMI: Body Mass Index; RDI: Respiratory Disturbances Index; 
AHI: Apnea-Hipopnea Index; REM: rapid eye movement; SpO2: Oxygen Saturation; TST: Total Sleep Time; WASO: Wake 
After Sleep Onset; p: Statistical Significance; *statistically different compared to CTRL group.
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presented more men (χ2 = 25.872, df = 1, p < 0.001), had 
higher body mass index (t = -11.8, df = 926, p < 0.0019), 
respiratory disturbances index (RDI) (t = -21.4, df = 918, p 
< 0.001), AHI (t = -27.4, df = 926, p < 0.001), desaturation 
index (t = -18.5, df = 769, p < 0.001), REM sleep latency 
(t = -3.318, df = 917, p = 0.001), percentage of N1 (t = 
-4.420, df = 926, p < 0.001), N2 (t = -3.084, df = 926, p 
= 0.002), N3 (t = 3.889, df = 926, p < 0.001), wake after 
sleep onset (t = -5.450, df = 926, p < 0.001) and lower 
total sleep time (t = 3.245, df = 926, p < 0.001), sleep 
efficiency (t = 5.023, df = 926, p < 0.001), basal, medium 
and minimum SpO2 (t = 12.8, df = 925, p < 0.001; t = 
13.9, df = 926, p < 0.001; t = 21.5, df = 926, p < 0.001, 
respectively) compared to the CTRL group. 
Table 2: Spearman´s correlation between leukocyte telomere length and polysomnographic parameters in the 
EPISONO cohort.
Polysomnographic Parameters rho p n
AHI -0.196 <0.001 928
RDI -0.155 <0.001 920
Dessaturation Index -0.182 <0.001 771
Basal SpO2 0.224 <0.001 927
Medium SpO2 0.235 <0.001 928
Minimum SpO2 0.200 <0.001 928
Arousal Index -0.147 <0.001 928
WASO -0.129 <0.001 928
Sleep Efficiency 0.127 <0.001 928
TST 0.074 0.023 928
Sleep Latency -0.045 0.171 928
REM Latency 0.018 0.589 919
N1 0.060 0.069 928
N2 -0.035 0.287 928
N3 0.056 0.086 928
REM 0.019 0.567 928
AHI: Apnea-Hipopnea Index; RDI: Respiratory Disturbances Index; SpO2: Oxygen Saturation; TST: Total Sleep Time; WASO: 
Wake After Sleep Onset; rho: Spearman’s Coefficient; p: Statistical Significance; n: Sample Size.
Figure 1: Mean telomere length expressed by T/S ratio among controls (CTRL) and obstructive sleep apnea syndrome 
(OSAS) group adjusted for age, body mass index and sex. *p < 0.001 compared to CTRL group.
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Moreover, OSAS was associated with higher 
frequency of diabetes (χ2 = 25.977, df = 3, p < 0.001). 
However, no significant association between the 
comorbidities history of heart attack, and stroke was 
observed with OSAS (χ2 = 3.130, df = 2, p = 0.201; χ2 
= 1.181, df = 2, p = 0.554; respectively), as well as no 
significant difference in years of schooling (t = 1.297, df 
= 922, p = 0.195), sleep latency (t = -1.062, df = 926, p = 
0.289) and percentage of REM sleep (t = 1.767, df = 926, 
p = 0.07) between the groups being found. 
Figure 1 illustrates the comparison of LTL adjusted 
for confounders in individuals with OSAS and CTRL. 
As hypothesized, OSAS presented shorter LTL (mean = 
1.32, SD = 0.22) than the CTRL (mean = 1.39, SD = 0.24) 
group (F = 27.010, df = 4, p < 0.001). The generalized 
linear model showed that in patients with OSAS (n = 315), 
OSAS severity (addressed by AHI) was associated with 
telomere length even after being adjusted for sex, age, 
body mass index, years of schooling, diabetes, stroke and 
heart attack (B = 0.055; CI = 0.007-0.102; p = 0.02). The 
post-hoc analysis showed that patients with mild OSAS 
had longer LTL (mean = 1.36, SD = 0.23) than those 
with severe OSAS (mean = 1.25, SD = 0.16). Moreover, 
patients with mild OSAS also had longer LTL than 
Table 3: Linear regression model considering T/S ratio as dependent variable and the sleep-related parameters as 
independent variables after controlling for age.
β t p
Age 0.26 -7.46 <0.001
Medium SpO2 0.08 2.32 0.02
Gender 0.06 1.75 0.08
BMI 0.04 1.03 0.30
AHI -0.33 -0.91 0.36
Sleep Efficiency -0.02 -0.044 0.66
Arousal Index -0.02 -0.61 0.54
BMI: Body Mass Index; AHI: Apnea-Hipopnea Index; SpO2: Oxygen Saturation; β:regression coefficient; t: t statistic; p: 
Statistical Significance.
Figure 2: Mean predicted values for leukocyte telomere length adjusted for the covariates in the model (sex, age, 
years of schooling, body mass index, diabetes, stroke and heart attack) in different levels of obstructive sleep apnea 
syndrome severity according to apnea-hypopnea index (AHI) ranges *p < 0.05 compared to 5 < AIH < 15 (mild 
obstructive sleep apnea syndrome).
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patients with moderate OSAS (mean = 1.28, SD = 0.20) (p 
= 0.02). No significant differences in LTL were observed 
between moderate and severe OSAS. Mean predicted 
values were calculated adjusted for the covariates in the 
model as shown in Figure 2. To address the relevance 
of the findings, Cohen´s D effect size was calculated 
regarding the difference in telomere length according to 
age or to AHI. Between the age groups 20-29 years and 
30-40 years, the effect size found in LTL was 0.17. In the 
comparison between CTRL and mild OSAS (5 ≤ AHI 
< 15), the effect size in LTL was -0.09; between CTRL 
and moderate OSAS (15 ≤ AHI < 30), it was 0.17; and 
between CTRL and severe OSAS (AHI ≥ 30), it was 0.21. 
Table 2 demonstrates the correlation between LTL 
and polysomnographic parameters in the EPISONO 
cohort. The results showed negative correlations between 
LTL assessed by the average T/S ratio and the following 
variables: AHI, RDI, desaturation index, arousal index 
and wake after sleep onset. LTL was positively correlated 
with total sleep time, sleep efficiency, basal, minimum and 
medium SpO2. No correlations were observed between 
LTL and the following variables: sleep latency, REM sleep 
latency, percentages of N1, N2, N3 and REM sleep. 
Table 3 represents the linear regression model 
considering as dependent variable T/S ratio. The results 
showed that age (β = 0.26, t = -7.46, p < 0.00) and medium 
SpO2 (β = 0.08, t = 2.32, p = 0.02) were predictors of 
telomere length in a model that explained about 98% of 
T/S variability. The variables excluded in the model were: 
gender, BMI, AHI, sleep efficiency and arousal index.
DISCUSSION
The current study showed that OSAS was associated 
with decreased LTL in comparison to CTRL individuals 
in an epidemiological sample from Sao Paulo. We also 
found that LTL was correlated with sleep fragmentation 
and hypoxia-related parameters, being the last one, 
represented by mean SpO2, one of the most important 
predictors of LTL, after age. Although evidence from the 
literature had already pointed to a relationship between 
sleep disordered breathing and LTL [18-21], the present 
study has described the relationship between LTL and 
the main pathophysiological parameters of OSAS using 
objective methods in a representative population sample.
Barcelo and colleagues (2010) have also described 
shorter LTL in patients with OSAS compared to controls, 
even after adjustments for potential confounders. 
However, contrary to the findings of our study, the 
severity of OSAS did not show a relationship with LTL 
[22]. Savolainen et al. (2014) in a cross-sectional study 
investigated whether a history of OSAS or primary 
snoring had an association with LTL in later adulthood. 
Records derived from Helsinki Birth Cohort Study 
were used and the OSAS diagnoses were based on the 
International Classification of Diseases (ICD). It was 
found that participants with a history of possible OSAS 
had shorter LTL than controls, whereas individuals with 
a history of primary snoring did not differ in LTL from 
controls, suggesting that shorter LTL could be a specific 
risk factor for OSAS [23]. However, Kim et al. (2010) 
in a study of the relationship between telomere length 
and OSAS in children observed, in contrast to what had 
been expected, that children with OSAS had an increase 
in LTL compared to controls [24]. In order to explain this 
finding, the authors hypothesized that OSAS could induce 
early mobilization of mesenchymal stem cells and that this 
could have a protective effect when stimulated by hypoxia 
or inflammatory mediators in children. Moreover, patients 
with OSAS exhibited lymphocytes in a highly activated 
state and the fact that these cells can express telomerase 
could explain the preservation of LTL in children with 
OSAS [24]. In addition, the ages of the participants and 
the subjective instruments used to characterize OSAS in 
the Kim et al study, may help to explain the inconsistency 
found.
Regarding the results from the multivariate analysis, 
we observed that hypoxia was the most important OSAS-
related factor associated with telomere length in our 
representative sample as we could see that medium SpO2 
remained significant after controlling for the confounders, 
differently from the variables associated with sleep 
fragmentation, such as arousal index and sleep efficiency. 
In accordance with our results, Boyer and colleagues 
(2016) observed in a sample of middle-aged males that 
intermittent hypoxia, via oxygen dessaturation index, was 
an important contributor to telomere shortening, even 
controlling for confounders [18]. Similarly, Choi and 
colleagues found that OSA had a significant association 
with short telomere length, increasing the risk of brain 
white matter changes in a community-based cohort of 
aged people [20].
In respect of sleep duration, the literature suggests 
that short sleep duration is associated with shorter 
LTL [25-30]. However, this interpretation needs to 
be approached with some caution since these studies 
evaluated LTL and sleep in different sexes, age groups 
and health conditions. Furthermore, these studies relied 
on self-report questionnaires to asses sleep duration and 
sleep quality, which may have affected the quality of 
the data. Using data derived from polysomnography, we 
found a negative correlation of LTL with arousal index and 
wake after sleep onset. In contrast, there was a positive 
correlation between LTL and sleep efficiency, as well with 
total sleep time. These results confirm the relationship 
between short sleepers and reduced LTL and indicate that 
sleep duration may also play a role in LTL shortening.
The interpretation of the factors related to LTL 
should be done with caution since the relationship found 
is not always simple. It is known that long telomeres are 
associated with decreased aging of many forms, but long 
telomeres are also associated with several cancers [13]. 
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It has already been established that LTL decreases with 
aging and that age-related diseases may play a role in the 
acceleration of this process. Moreover, cumulative levels 
of oxidative stress and inflammation may also influence 
telomere length [31]. In the present study, we found that 
LTL was shorter in OSAS individuals than in CTRL. 
We also observed correlations between sleep parameters 
which may suggest mechanisms for the relationship found 
between OSAS and LTL. Unlike the other studies, the 
severity of OSAS did show a relationship with LTL, even 
after adjusting for potential confounders. 
Telomere length is a biomarker of aging very 
sensible to external stressors. Although a number of 
damage-causing mechanisms are needed to cause 
substantial changes in telomere length, as humans age, 
average telomere length declines and mortality increases. 
Thus, a small change in human white blood cell telomeres 
has a great functional impact than its absolute magnitude 
might suggest. The average change observed in LTL 
between controls and severe OSAS had an effect size of 
0.21, an effect higher than the effect size regarding LTL 
in 2 groups with 10 years of age difference (0.17). Thus, 
we believe that OSAS may contribute to the attrition of 
telomere length and promote accelerated aging. 
Despite the fact that the current study is cross-
sectional, and thus causality cannot be inferred, the data 
found may encourage future prospective and experimental 
studies aiming to provide the possible molecular pathways 
underlying the relationship observed between OSAS and 
LTL, independent of aging. However, as a speculative 
hypothesis, we can argue that a possible mechanism relies 
on the cascade of events involving intermittent hypoxia/
sleep fragmentation leading to increased production of 
ROS and pro-inflammatory cytokines, which are well-
known factors able to shorten telomeres [22]. 
This study has some limitations. First, the 
cross-sectional design does not allow causality, only 
association. Second, there was no adaptation night for 
polysomnography. However, studies show good agreement 
between the first and second night of polysomnography for 
respiratory events, which were the main outcome in the 
current study [32]. Third, it is known that telomere length 
and its response to stresses varies by tissue, i.e., short-lived 
cells may be more expressive for genetic factors, whereas 
long-lived cells in other tissues may be more expressive 
for the effects of comorbidities such as OSAS [13]. Thus, 
as in the current study the telomere length was measured 
in leukocytes (short-lived cells) for ethical reasons, we 
may assume that the results could be more expressive if 
done in other target cells. 
Taken together, our findings showed that OSAS is 
associated with telomere shortening in AHI-dependent 
manner, increasing with disease severity. Moreover, in 
respect to OSAS-related factors, although sleep quality 
and duration are important, hypoxia seems to be a major 
contributor in the acceleration of telomere shortening. 
Therefore, the present study supports the idea of a possible 
relationship between the pathophysiology of OSAS and 
the molecular pathways of cell aging being related to 
the maintenance of telomere length. Prospective and 
experimental studies are essential to establish whether 
there is a causal relationship between OSAS and telomere 
shortening, and the possible mechanisms involved.
MATERIALS AND METHODS
Studied sample
This is part of a cross-sectional study called 
Sao Paulo Epidemiologic Sleep Study (EPISONO), 
a population-based survey, in which 1042 subjects 
underwent polysomnography and were investigated 
through sleep questionnaires and blood sample 
measurements. In order to adequately represent the 
inhabitants of Sao Paulo in 2007 according to gender, age 
(20-80 years), and socioeconomic class, a probabilistic 
three-stage cluster sample was used. A sample size 
was defined to allow for prevalence estimates with 3% 
precision [33]. The study protocol was approved by 
the Ethics Committee for Research of the Universidade 
Federal de São Paulo (CEP 0593/06) and registered 
with ClinicalTrials.gov (number: NCT00596713; 
name: Epidemiology of sleep disturbances among adult 
population of the Sao Paulo City). Written informed 
consent forms were completed and signed by all 
participants before their inclusion in the study.
Polysomnography assessment
All individuals were subjected to 1 full-night 
polysomnography at the sleep laboratory using the 
EMBLA® N7000 system (Embla Systems Inc., 
USA). Sleep stages were visually scored by trained 
technicians according to standardized criteria for 
investigating sleep [34, 35]. The exam was scheduled 
according to the volunteers’ availability to try to respect 
their habitual sleep schedule, which was assessed 
through interview during home visit. Physiological 
variables evaluated during polysomnography included: 
electroencephalogram (4 channels: C3-A2, C4-A1, 
O1-A2, O2-A1); electrooculogram (2 channels: EOG-
Left-A2, EOG-Right-A1); surface electromyogram 
(4 channels: submentonian region, masseter region, 
anterior tibialis muscle and seventh intercostal space); 
electrocardiogram (1 channel: derivation V1 modified); 
air flow (2 channels: thermocouple and nasal pressure); 
respiratory effort (2 channels: thorax and abdomen) by 
inductance plethysmography belts; snoring and body 
position (1 channel each) by EMBLA® sensors; and 
oxygen saturation (SpO2) by EMBLA® oximeter, which 
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allowed the measurement of mean and minimum SpO2 
both basal, when the patient was awake, and twice with 
the patient sleeping . The exam was performed according 
to specific criteria for the definition of sleep stages [34]. 
The American Academy of Sleep Medicine Manual 
for Scoring Sleep and Associated Events [35] was the 
reference used to score sleep-related respiratory events 
and arousals. Hypopneas were scored in accordance with 
the following rule: a decrease of 50% in the respiratory 
flow associated with arousal or 3% oxygen dessaturation 
[35]. The desaturation index comprised the number of 
incidents of 3% desaturation per hour of sleep, while the 
respiratory disturbance index was defined as the total 
number of obstructive respiratory events (apnea, hypopnea 
and respiratory effort related arousals).
Diagnosis of obstructive sleep apnea syndrome
The present study included individuals with 
OSAS and controls. In accordance with the International 
Classification of Sleep Disorders (2005), OSAS was 
considered positive when individuals had an AHI of 
between 5 and 14.9, and had at least one of the following 
symptoms: loud snoring, daytime sleepiness, fatigue 
and respiratory cessations during sleep. Additionally, 
individuals with an AHI of 15 or above were also found 
positive, regardless of the presence of the above mentioned 
symptoms [36]. OSAS severity was addressed by apnea-
hypopnea index, which classifies individuals with OSAS 
as: mild (5 ≤ AHI < 15), moderate (15 ≤ AHI < 30) and 
severe (AHI ≥ 30) [37]. Individuals that did not fulfill 
OSAS criteria were considered as controls (CTRL).
Measurement of leukocyte telomere length
On the morning after the polysomnography, all 
volunteers had 10 mL of blood collected in EDTA tubes 
for DNA extraction. The DNA was extracted using the 
salting-out method, according to the Miller et al protocol 
[38]. After isolation, the DNA samples were quantified 
and diluted to 50 ng/ul. Telomere length measurement 
was performed by multiplex real time PCR, as described 
by Cawthon with some modifications [39]. Measurement 
consists of determining the relative ratio (T/S ratio) of ng 
of telomeres (T) to ng of albumin (single-copy gene, S) 
in experimental samples using a standard curve. The T/S 
ratio is proportional to the average telomere length.
A total of 928 samples were analyzed. There 
was a loss of a total of 114 samples due to: insufficient 
concentration (17 samples), insufficient volume (37 
samples) and to the failure of some participants to fully 
complete the information questionnaire (60 samples). 
The final volume in the reaction wells was 25µL and 
contained: 12.5µL of 2x SYBR® Select Master Mix (Life-
Thermo Fischer Scientific, 4472920); 1µL sample DNA; 
0.9µL of 25µM telg (final concentration 900nM); 0.6µL of 
25µM telc (600nM); 0.9µL of 25µM albu (900nM); 0.9µL 
of 25µM albd (900nM) (20) and 8.2µL of UltraPure™ 
DNase⁄RNase-Free Distilled Water (Life-Thermo Fischer 
Scientific, 10977035). The standard curve was built based 
on a five-point 1:3 serial dilution DNA from a single 
individual (range from 150 to 1.85ng). The samples and 
standard curve were all run in triplicate in a ViiA™ 7 
Real-Time PCR System with fast 96-Well Block (Life-
Thermo Fischer Scientific, USA).
The conditions of PCR amplifications were: 15 
minutes at 95°C, 2 cycles of 15 seconds at 94°C, 15 
seconds at 49°C, 35 cycles of 15 seconds at 94°C, 10 
seconds at 68°C and 15 seconds at 74°C with acquisition 
of fluorescence (detection of telomere amplification), 10 
seconds at 85°C, 15 seconds at 88°C with acquisition of 
fluorescence (detection of albumin amplification) and the 
melting curve.
In all runs, a seriated dilution from a standard DNA 
was added in order to construct a standard curve used to 
relatively quantify telomere length in relation to albumin 
gene (T/S Ratio) [39]. 
Statistical analysis
Normality was determined by Kolmogorov-
Smirnov’s test. All variables that presented non-normal 
distribution were standardized by z-score before we 
ran an independent T-test on the simple comparisons 
between the OSAS and CTRL group. Chi-square test was 
used to verify possible associations between categorical 
variables, and consequently to identify confounding 
factors. Correlations between LTL (T/S Ratio) and 
polysomnographic parameters were examined using 
Spearman´s correlation. In addition, the LTL comparison 
between the OSAS and CTRL groups was performed 
using analysis of covariance (ANCOVA), adjusted for 
the confounders age, body mass index and sex. Lastly, in 
order to determine the effect of OSAS severity (by AHI) 
on LTL, a generalized linear model (GLzMM) was used 
with Gamma distribution for sex, age, body mass index, 
years of schooling, diabetes, stroke and heart attack as 
independent variables (confounders) and T/S ratio as 
the dependent variable. Linear regression model was 
constructed for T/S ratio using the stepwise procedure. We 
considered as independent variables: age, gender, BMI, 
AHI, sleep efficiency, arousal index and medium SpO2. 
Furthermore, effect size for telomere length variance was 
calculated through the Cohen´s D formula. Statistical 
significance was defined as 5%.
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